Stay updated on Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial

Sign up to get notified when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Expanded the study location listing to include numerous new sites across the US, Argentina, Australia, Europe, Asia, and other regions, while removing several previously listed locations.
    Difference
    3%
    Check dated 2025-12-23T09:18:45.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is a routine update and does not affect study content, eligibility, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:20:58.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The study documents section shows a revision update from v3.2.0 to v3.3.1. This appears to be a minor documentation update with no changes to the study design, eligibility criteria, or outcomes.
    Difference
    0.0%
    Check dated 2025-11-24T13:11:59.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    Removed the notice about a lapse in government funding and related operating status guidance (cc.nih.gov and opm.gov references) from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T06:26:53.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    New results posting details were added to the page (Results First Submitted 2025-02-28 and Results First Posted 2025-04-13) along with updated Study Record Dates, introducing outcome reporting information to the page.
    Difference
    0.2%
    Check dated 2025-11-03T01:06:01.000Z thumbnail image
  9. Check
    66 days ago
    Change Detected
    Summary
    Cali, Colombia (760035) was added as a study location, and Santiago de Cali, Colombia (760035) was removed. This updates the list of sites where the trial is conducted and where participants can enroll.
    Difference
    0.1%
    Check dated 2025-10-26T20:36:57.000Z thumbnail image

Stay in the know with updates to Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.